Recombinant multi-species SURVIVIN/BIRC5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SURVIVIN/BIRC5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is a member of the inhibitor of apoptosis (IAP) gene family, which encode negative regulatory proteins that prevent apoptotic cell death. IAP family members usually contain multiple baculovirus IAP repeat (BIR) domains, but this gene encodes proteins with only a single BIR domain. The encoded proteins also lack a C-terminus RING finger domain. Gene expression is high during fetal development and in most tumors, yet low in adult tissues. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jun 2011]
The Alternative Names of target: AAC-11,AP14,API4,Api4,Apoptosis inhibitor 4,Apoptosis inhibitor survivin,BIRC5,Baculoviral IAP repeat-containing protein 5,Birc5,EPR-1,SURVIVIN,TIAP,survivin40

Target products collectionGo to SURVIVIN/BIRC5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T02677-Ag-1/ GM-Tg-hg-T02677-Ag-2 Human SURVIVIN/BIRC5 protein Human
GM-Tg-rg-T02677-Ag-1/ GM-Tg-rg-T02677-Ag-2 Rat SURVIVIN/BIRC5 protein Rat
GM-Tg-mg-T02677-Ag-1/ GM-Tg-mg-T02677-Ag-2 Mouse SURVIVIN/BIRC5 protein Mouse
GM-Tg-cynog-T02677-Ag-1/ GM-Tg-cynog-T02677-Ag-2 Cynomolgus/Rhesus macaque SURVIVIN/BIRC5 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T02677-Ag-1/ GM-Tg-felg-T02677-Ag-2 Feline SURVIVIN/BIRC5 protein Feline
GM-Tg-cang-T02677-Ag-1/ GM-Tg-cang-T02677-Ag-2 Canine SURVIVIN/BIRC5 protein Canine
GM-Tg-bovg-T02677-Ag-1/ GM-Tg-bovg-T02677-Ag-2 Bovine SURVIVIN/BIRC5 protein Bovine
GM-Tg-equg-T02677-Ag-1/ GM-Tg-equg-T02677-Ag-2 Equine SURVIVIN/BIRC5 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T02677-Ag-1/ GM-Tg-hg-T02677-Ag-2; GM-Tg-rg-T02677-Ag-1/ GM-Tg-rg-T02677-Ag-2;
GM-Tg-mg-T02677-Ag-1/ GM-Tg-mg-T02677-Ag-2; GM-Tg-cynog-T02677-Ag-1/ GM-Tg-cynog-T02677-Ag-2;
GM-Tg-felg-T02677-Ag-1/ GM-Tg-felg-T02677-Ag-2; GM-Tg-cang-T02677-Ag-1/ GM-Tg-cang-T02677-Ag-2;
GM-Tg-bovg-T02677-Ag-1/ GM-Tg-bovg-T02677-Ag-2; GM-Tg-equg-T02677-Ag-1/ GM-Tg-equg-T02677-Ag-2
Products Name SURVIVIN/BIRC5 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name SURVIVIN/BIRC5
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SURVIVIN/BIRC5 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.